Takeda Pharmaceutical
Takeda Pharmaceutical

TAK - Takeda Pharmaceutical • Dividends

Takeda Pharmaceutical is Japan’s largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company’s five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding DateValue (U$)Frequency
3/31/2026
0,308
Biannual
9/30/2025
0,322
Biannual
3/31/2025
0,339
Biannual
9/30/2024
0,326
Biannual
3/27/2024
0,292
Biannual
9/28/2023
0,319
Biannual
3/30/2023
0,31
Biannual
9/29/2022
0,33
Biannual
3/30/2022
0,33
Biannual
9/29/2021
0,397
Biannual
3/30/2021
0,407
Biannual
9/29/2020
0,431
Biannual
3/30/2020
0,419
Biannual
9/27/2019
0,411
Biannual
3/28/2019
0,417
Biannual

The latest dividend from TAK was $0.308 per share (ex-dividend 3/31/2026). The dividend yield over the last 12 months is 3,1%. Over the last 12 months there were 2 distributions, totalling $0.63 per share.